NMR Studies of Tau Protein in Tauopathies

被引:8
|
作者
Kitoka, Kristine [1 ]
Skrabana, Rostislav [2 ,3 ]
Gasparik, Norbert [4 ,5 ]
Hritz, Jozef [4 ,6 ]
Jaudzems, Kristaps [1 ,7 ]
机构
[1] Latvian Inst Organ Synth, Lab Phys Organ Chem, Riga, Latvia
[2] Slovak Acad Sci, Inst Neuroimmunol, Bratislava, Slovakia
[3] AXON Neurosci R&D Serv SE, Bratislava, Slovakia
[4] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic
[5] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic
[6] Masaryk Univ, Fac Sci, Dept Chem, Brno, Czech Republic
[7] Univ Latvia, Fac Chem, Riga, Latvia
基金
欧盟地平线“2020”;
关键词
tau; nuclear magnetic resonance; protein structure; Alzheimer's disease; filaments; MICROTUBULE-BINDING DOMAIN; PAIRED HELICAL FILAMENTS; NUCLEAR-MAGNETIC-RESONANCE; 3RD REPEAT FRAGMENT; FULL-LENGTH TAU; ALZHEIMERS-DISEASE; STRUCTURAL-CHARACTERIZATION; ALPHA-SYNUCLEIN; RANDOM-COIL; NEUROFIBRILLARY TANGLES;
D O I
10.3389/fmolb.2021.761227
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tauopathies, including Alzheimer's disease (AD), are the most troublesome of all age-related chronic conditions, as there are no well-established disease-modifying therapies for their prevention and treatment. Spatio-temporal distribution of tau protein pathology correlates with cognitive decline and severity of the disease, therefore, tau protein has become an appealing target for therapy. Current knowledge of the pathological effects and significance of specific species in the tau aggregation pathway is incomplete although more and more structural and mechanistic insights are being gained using biophysical techniques. Here, we review the application of NMR to structural studies of various tau forms that appear in its aggregation process, focusing on results obtained from solid-state NMR. Furthermore, we discuss implications from these studies and their prospective contribution to the development of new tauopathy therapies.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] TAU PROTEIN AND HUMAN TAUOPATHIES: AN OVERWIEV
    Mohorko, Nina
    Bresjanac, Mara
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : II35 - II41
  • [2] Tau protein as a differential biomarker of tauopathies
    Sergeant, N
    Delacourte, A
    Buée, L
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3): : 179 - 197
  • [3] Nitration of tau protein is linked to neurodegeneration in tauopathies
    Horiguchi, T
    Uryu, K
    Giasson, BI
    Ischiropoulos, H
    LightFoot, R
    Bellmann, C
    Richter-Landsberg, C
    Lee, VMY
    Trojanowski, JQ
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (03): : 1021 - 1031
  • [4] Tau and tauopathies
    Robert, M.
    Mathuranath, P. S.
    NEUROLOGY INDIA, 2007, 55 (01) : 11 - 16
  • [5] Tau and tauopathies
    Arendt, Thomas
    Stieler, Jens T.
    Holzer, Max
    BRAIN RESEARCH BULLETIN, 2016, 126 : 238 - 292
  • [6] Tau and Tauopathies
    Lee, Gloria
    Leugers, Chad J.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES, 2012, 107 : 263 - 293
  • [7] Tau protein profiling in tauopathies: a human brain study
    Lantero-Rodriguez, Juan
    Camporesi, Elena
    Montoliu-Gaya, Laia
    Gobom, Johan
    Piotrowska, Diana
    Olsson, Maria
    Burmann, Irena Matecko
    Becker, Bruno
    Brinkmalm, Ann
    Burmann, Bjorn M.
    Perkinton, Michael
    Ashton, Nicholas J.
    Fox, Nick C.
    Lashley, Tammaryn
    Zetterberg, Henrik
    Blennow, Kaj
    Brinkmalm, Gunnar
    MOLECULAR NEURODEGENERATION, 2024, 19 (01)
  • [8] Tau and tauopathies: tau phosphorylation and tau assembly
    Avila, J.
    FEBS JOURNAL, 2006, 273 : 23 - 23
  • [9] Tau PET and tauopathies
    Karl Herholz
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1684 - 1685
  • [10] Tau PET and tauopathies
    Herholz, Karl
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (09) : 1684 - 1685